Quarterly Financial Data

12 Months Ended

Jan. 03, 2015

Quarterly Financial Data [Abstract]

Quarterly Financial Information [Text Block]

QUARTERLY FINANCIAL DATA (UNAUDITED)

	First		Second		Third		Fourth
(in millions, except per share amounts)	Quarter		Quarter		Quarter		Quarter
Fiscal Year 2014:
Net sales	$	1,363	$	1,448	$	1,372	$	1,439
Gross profit	980		1,015		960		1,014
Net earnings before noncontrolling interest	239		246		232		238
Net earnings attributable to St. Jude Medical, Inc.	249		270		238		245
Basic net earnings per share attributable to St. Jude Medical, Inc.	$	0.88	$	0.95	$	0.83	$	0.86
Diluted net earnings per share attributable to St. Jude Medical, Inc.	$	0.86	$	0.93	$	0.82	$	0.84
Fiscal Year 2013:
Net sales	$	1,338	$	1,403	$	1,338	$	1,422
Gross profit	961		1,021		953		992
Net earnings before noncontrolling interest	222		107		252		111
Net earnings attributable to St. Jude Medical, Inc.	223		115		262		123
Basic net earnings per share attributable to St. Jude Medical, Inc.	$	0.78	$	0.41	$	0.91	$	0.42
Diluted net earnings per share attributable to St. Jude Medical, Inc.	$	0.78	$	0.40	$	0.90	$	0.42

During the first, second, third and fourth quarters of 2014, the Company recognized after-tax charges of $25 million, $21 million, $39 million and $65 million, respectively, in its Net earnings attributable to St. Jude Medical, Inc. These charges primarily related to the 2012 Business Realignment Plan and Manufacturing and Supply Chain Optimization Plan, acquisition-related charges, intangible asset impairment charges, product field action and litigation charges and legal settlement expenses, partially offset by income tax benefits for discrete income tax adjustments and a favorable legal settlement. See Notes 2, 6, 8, 9 and 11 for further information.

During the first, second and fourth quarters of 2013, the Company recognized after-tax charges of $40 million, $160 million and $171 million, respectively, in its Net earnings attributable to St. Jude Medical, Inc. These charges primarily related to the 2012 Business Realignment Plan and 2011 Restructuring Plan, debt retirement costs associated with the make-whole redemption payments and the write-off of unamortized debt issuance costs, acquisition-related charges, product field action and litigation charges, a legal settlement charge and an income tax expense charge related to uncertain tax positions in foreign jurisdictions, partially offset by income tax benefits from enactment of a tax law and the settlement of domestic tax audits. See Notes 2, 4, 6, 8, 9 and 11 for further information.